Yahoo Web Search

Search results

1. • 

     GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk

     Reuters via Yahoo Finance· 6 hours ago

     (Reuters) -GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of...

2. • 

     FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro

     Bloomberg via Yahoo News· 1 year ago

     (Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...

3. • 

     Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms

     Investor's Business Daily· 2 years ago

     Pharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...

4. • 

     FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns

     Yahoo Finance UK· 2 years ago

     GSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...

5. • 

     First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.

     USA TODAY via Yahoo News· 1 year ago

     For people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...

6. • 

     Pharma Stock Roundup: SNY, GSK, PFE Relieved on Zantac Win & Other Updates

     Zacks via Yahoo Finance· 1 year ago

     A U.S. district court dismisses thousands of lawsuits involving Zantac, which spells relief for GSK...

7. • 

     Sanofi to settle 4,000 lawsuits claiming Zantac is linked to cancer

     Scripps News via AOL· 2 months ago

     A box of Maximum Strength Zantac tablets at a pharmacy The French pharmaceutical company Sanofi says...

8. • 

     PFE, GSK & Other Pharma Stocks Hit by Zantac Litigation

     Zacks via Yahoo Finance· 2 years ago

     Big pharma stocks, such as Glaxo (GSK), Sanofi (SNY), Pfizer (PFE) and Consumer stock Haleon (HLN),...

9. • 

     GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023

     Benzinga via Yahoo Finance· 1 year ago

     The first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated...

10. • 

      First Zantac cancer risk trial in Calif. postponed five months

      Reuters via Yahoo News· 1 year ago

      (Reuters) -The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer,...